Page last updated: 2024-09-03

rc 3095 and Brain Neoplasms

rc 3095 has been researched along with Brain Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Battastini, AM; Braganhol, E; Brunetto, AL; Cechim, G; de Castro, CG; de Oliveira, MS; Lenz, G; Meurer, L; Roesler, R; Santos, DG; Schwarstmann, G; Schwartsmann, G1
Armatis, P; Groot, K; Kiaris, H; Schally, AV; Sun, B1

Other Studies

2 other study(ies) available for rc 3095 and Brain Neoplasms

ArticleYear
Anti-proliferative effect of the gastrin-release peptide receptor antagonist RC-3095 plus temozolomide in experimental glioblastoma models.
    Journal of neuro-oncology, 2009, Volume: 93, Issue:2

    Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bombesin; Brain Neoplasms; Cell Division; Cell Line, Tumor; Cell Survival; Dacarbazine; Exploratory Behavior; Flow Cytometry; Glioblastoma; Male; Peptide Fragments; Rats; Rats, Wistar; Receptors, Bombesin; Temozolomide

2009
Inhibition of growth of human malignant glioblastoma in nude mice by antagonists of bombesin/gastrin-releasing peptide.
    Oncogene, 1999, Nov-25, Volume: 18, Issue:50

    Topics: Animals; Base Sequence; Bombesin; Brain Neoplasms; Cell Division; DNA Primers; Gastrin-Releasing Peptide; Glioblastoma; Humans; Mice; Mice, Nude; Peptide Fragments; Proto-Oncogene Proteins c-fos; RNA, Messenger

1999